Insider Trading History of Sablich Kim

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Sablich Kim since 2019. This trader's CIK number is 1758790. At the time of last reporting, Sablich Kim was the EVP, GM of U.S., Commercial Ma of Jazz Pharmaceuticals Plc. (stock ticker symbol JAZZ). Also see all insider trading activities at Jazz Pharmaceuticals Plc.

Note that in the past Sablich Kim also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Myovant Sciences Ltd. (MYOV) by Sablich Kim

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 MYOV 0 $0 5,625 $73,569 0 $0
2019 MYOV 0 $0 2,585 $41,928 0 $0

Yearly summary of insider trading at Jazz Pharmaceuticals Plc (JAZZ) by Sablich Kim

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 JAZZ 0 $0 3,013 $421,232 0 $0
2022 JAZZ 0 $0 3,829 $578,591 0 $0
2021 JAZZ 0 $0 2,748 $370,999 0 $0


Insider trading activities at 2 companies by Sablich Kim:

1. Myovant Sciences Ltd. (MYOV)

2. Jazz Pharmaceuticals Plc (JAZZ)

Table 1. Insider trading of Myovant Sciences Ltd. (MYOV) by Sablich Kim

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-03-18 MYOV Sale 785 7.16 5,616
2020-01-15 MYOV Sale 4,840 14.04 67,953
2019-12-18 MYOV Sale 2,585 16.22 41,928

Table 2. Insider trading of Jazz Pharmaceuticals Plc (JAZZ) by Sablich Kim

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-03-08 JAZZ Sale 3,013 139.81 421,232
2022-06-07 JAZZ Sale 2,441 150.51 367,407
2022-06-06 JAZZ Sale 1,388 152.15 211,184
2021-11-11 JAZZ Sale 2,748 135.01 370,999

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sablich Kim (EVP, GM of U.S., Commercial Ma of Jazz Pharmaceuticals Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.